Andrew Davies joins ABHI
This article was originally published in Clinica
Executive Summary
Forearming for the commercial access battles ahead, the UK medical devices industry association, ABHI, has appointed Andrew Davies as director of market access. Mr Davies, who has worked within the medical technology divisions of Thorn EMI, Philips and Bristol-Myers Squibb, has responsibility for ensuring that UK reimbursement structures are appropriate to the current evaluation and adoption models for medical devices. The maintenance of efficient access and payment structures requires ongoing dialogue between industry and policy makers, in which task the new ABHI director can bring to bear 20 years of medical devices industry experience, including roles in UK and international marketing and business development in the capital and consumable equipment sectors. The ABHI has also appointed senior registrar in anaesthetics Dr William Wynn-Jones as clinical fellow for one year, in which role he will help build relationships between NHS clinicians and the medical technologies industry as regards working within the NHS Outcomes Framework.